Publicaciones (104) Publicaciones de JUAN TORRES MACHO

2024

  1. CHEDDAR score versus YEARS algorithm for suspected pulmonary embolism in SARS-CoV-2-infected patients: A comparison of two strategies

    European Journal of Internal Medicine

  2. Correction to: Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review (Infection, (2024), 52, 1, (43-58), 10.1007/s15010-023-02154-0)

    Infection

  3. Executive summary of the consensus document for the training and development of clinical ultrasound in internal medicine: Recommendations from the Clinical Ultrasound Working Group of the Spanish Society of Internal Medicine (GTECO-SEMI)

    Revista Clinica Espanola, Vol. 224, Núm. 1, pp. 57-63

  4. External validation of the RIETE and SOME scores for occult cancer in patients with venous thromboembolism: a multicentre cohort study

    Clinical and Translational Oncology

  5. Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

    Viruses, Vol. 16, Núm. 2

  6. Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review

    Infection, Vol. 52, Núm. 1, pp. 43-58

  7. On-site testing and treatment of sexually transmitted infections among female sex workers using molecular point-of-care testing integrated into harm reduction services in Madrid, Spain

    International Journal of Drug Policy, Vol. 123

  8. Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms 2 years after hospitalization: The VIPER study

    Journal of Medical Virology, Vol. 96, Núm. 5

  9. Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms: a systematic review of the literature

    Clinical Chemistry and Laboratory Medicine, Vol. 62, Núm. 6, pp. 1044-1052

  10. Serological biomarkers at hospital admission and hospitalization treatments are not related to the development of post-COVID dyspnea

    European Journal of Internal Medicine

  11. Systematic review of clinical trials on the antithrombotic therapy with factor XI inhibitors

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 167-177

  12. Ultrasound assessment of the inferior vena cava in heart failure

    Medicina Clinica

2023

  1. Acute phase characteristics and long-term complications of pulmonary embolism in COVID-19 compared to non-COVID-19 cohort: a large single-centre study

    BMC pulmonary medicine, Vol. 23, Núm. 1, pp. 25

  2. Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors

    Infection, Vol. 51, Núm. 1, pp. 61-69

  3. Could We Consider Ultrasound-Guided Minimally Invasive Autopsy as a Part of POCUS?

    Journal of Ultrasound in Medicine, Vol. 42, Núm. 8, pp. 1887-1892

  4. External validation of the CHEDDAR score for suspected pulmonary embolism in patients with SARS-CoV-2 infection in an independent cohort

    Journal of Thrombosis and Thrombolysis

  5. Inter-Rater Variability in the Evaluation of Lung Ultrasound in Videos Acquired from COVID-19 Patients

    Applied Sciences (Switzerland), Vol. 13, Núm. 3

  6. Long-Haul COVID Symptoms in Persons with Diabetes

    Contemporary Endocrinology (Humana Press Inc.), pp. 207-215

  7. Lung ultrasound must be the first-line image technique in COVID-19 patients

    European Journal of Internal Medicine

  8. Main applications of point-of care ultrasound in palliative care

    Revista Clinica Espanola, Vol. 223, Núm. 6, pp. 371-378